Skip to main content
PepStack
Blutwerte · Marker

RDW

Red Cell Distribution Width · Anisozytose-Index

Blutbild
Einheit:
%

RDW quantifies the variation in size of red blood cells in a blood sample.

Reference Ranges

Reference
11.514.5%
11.5
13.5
14.5
LowNormalHigh
Reference
Optimal
Unit · %

Reference ranges may vary slightly based on laboratory standards and population demographics.

Overview

Übersicht

Red Cell Distribution Width (RDW) is a hematological parameter that measures the variation in size (anisocytosis) of circulating red blood cells (RBCs). It is calculated as part of a standard complete blood count (CBC) and provides insights into the heterogeneity of erythrocyte sizes. Clinically, RDW is an important marker for diagnosing and monitoring various conditions, including anemia, cardiovascular diseases, and inflammatory disorders. Elevated RDW values have been associated with increased severity and poor prognosis in diseases such as acute pancreatitis, Alzheimer's disease, and chronic obstructive pulmonary disease (COPD). In the context of athletic performance, biohacking, and longevity, RDW may serve as an indirect marker of systemic inflammation and oxidative stress, which are critical factors in aging and recovery processes. However, the utility of RDW in these areas requires further investigation. Researchers have noted that RDW can be influenced by various factors, including nutritional deficiencies, chronic diseases, and acute inflammatory states. Additionally, inter-individual variability and potential pre-analytical errors, such as improper sample handling, can affect RDW measurements. Therefore, RDW should be interpreted in conjunction with other clinical findings and laboratory tests to provide a comprehensive assessment of an individual's health status.

Klinische Bedeutung

Elevated RDW values indicate increased heterogeneity in RBC size, often reflecting underlying conditions such as anemia, inflammation, or chronic disease. Low RDW values are less common and generally not clinically significant.

Dynamics

Trend Interpretation

Rising Values

Progressively rising RDW values may indicate worsening anemia or increased inflammation. Re-test in 4-6 weeks if clinically indicated.

Falling Values

Progressively falling RDW values may suggest improvement in underlying conditions such as anemia.

Re-test Interval

4-6 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Iron deficiency anemia
  • Vitamin B12 deficiency
  • Chronic inflammation
  • Liver disease
  • Cardiovascular disease
  • Chronic kidney disease
Cause

Low Levels

  • Recent blood transfusion
  • Microcytic anemia
  • Thalassemia
  • Sickle cell disease
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Adequate sleep
  • Stress management
Lever

Nutrition

  • Iron-rich foods
  • Vitamin B12 supplementation
  • Folate-rich foods
Lever

Supplementation

  • Iron supplements
  • Vitamin B12
  • Folic acid

Note:

Consult a healthcare provider before starting any supplementation, especially if underlying health conditions are present.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

Testing Frequency

Annually as part of a complete blood count for routine health assessments.

Interfering Factors

  • Recent blood transfusion
  • Sample hemolysis
  • Improper sample storage

Open Research Questions

Current research suggests that the inter-individual and intra-individual variability of RDW values complicates its use as a definitive biomarker, with reference ranges and optimal targets still debated. Emerging research directions include exploring RDW's role in various inflammatory conditions and its potential as a universal biomarker for disease severity. However, clinical questions remain unanswered regarding the specific mechanisms linking RDW to disease processes and its predictive value across different patient populations.

33 Research Publications

306

Total Citations

25

Human/RCT

1.6

Avg. Influence

2025

Latest

Sort
Filter
#01

Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)?

HumanInfluence2.0
66
This study assessed the relationship between red cell distribution width (RDW) and Alzheimer's disease (AD). Researchers found that RDW values were significantly higher in AD patients compared to controls, and there was a moderate negative correlation between RDW and cognitive function. Elevated RDW may indicate inflammation's role in AD pathophysiology.
View on PubMed
#02

The Emerging Clinical Significance of the Red Cell Distribution Width as a Biomarker in Chronic Obstructive Pulmonary Disease: A Systematic Review.

Meta-Analysis
27
This systematic review investigated the role of red cell distribution width (RDW) as a biomarker in chronic obstructive pulmonary disease (COPD). Researchers found significant associations between RDW and disease presence, severity, and outcomes like mortality and hospital readmission in stable COPD and acute exacerbations. The findings suggest RDW could aid in diagnosis and risk stratification.
View on PubMed
#03

Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer.

Human
27
Researchers found that RDW is significantly elevated in non-small cell lung cancer (NSCLC) patients compared to healthy individuals. The study suggests that RDW may enhance diagnostic performance and correlate with disease stage in NSCLC.
View on PubMed
#04

Association Between Variation in Red Cell Size and Multiple Aging-Related Outcomes.

HumanInfluence1.0
24
Researchers found that greater variability in red blood cell size, indicated by RDW, is linked to increased functional limitations, frailty, and cognitive decline in older men. Higher RDW was also associated with a greater risk of falls and hospitalization. These findings suggest RDW may serve as a marker for biological aging.
View on PubMed
#05

Red cell distribution width in migraine.

HumanInfluence2.0
24
This study explored the relationship between red cell distribution width (RDW) and migraine. Researchers found that RDW was significantly higher in migraine patients compared to controls and positively correlated with attack duration. Elevated RDW may indicate underlying inflammatory processes related to migraine.
View on PubMed
#06

Utility of Red Cell Distribution Width (RDW) as a Noninvasive Biomarker for the Diagnosis of Acute Appendicitis: A Systematic Review and Meta-Analysis of 5222 Cases.

Meta-Analysis
24
This systematic review and meta-analysis investigated red cell distribution width (RDW) as a diagnostic biomarker for acute appendicitis (AA). Researchers found no statistically significant difference in RDW values between AA patients and controls, indicating that RDW may not be a reliable marker for diagnosing AA at this time.
View on PubMed
#07

Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation.

UnknownInfluence1.0
22
This review examined the clinical significance of red cell distribution width (RDW) in atrial fibrillation (AF). Researchers found that elevated RDW values are predictive of AF and may indicate a higher risk of complications such as hospitalization and thromboembolic events. RDW measurement could enhance patient management strategies.
View on PubMed
#08

Association between red cell distribution width/serum albumin ratio and diabetic kidney disease.

Chen Jiaqi, et al. · Journal of diabetes · 2024

HumanInfluence1.0
21
This study examined the association between the RDW/serum albumin ratio and diabetic kidney disease. Researchers found that higher RDW/albumin ratios are independently linked to an increased risk of DKD in diabetic patients.

Key findings

  1. 01Higher RA levels in diabetic patients were linked to a greater risk of developing diabetic kidney disease.
  2. 02The study analyzed data from over 4,500 diabetic patients across two large health databases.
  3. 03RA may serve as a cost-effective tool for assessing kidney disease risk in diabetes patients.
View on PubMed
#09

Red Blood Cells and Human Aging: Exploring Their Biomarker Potential.

Review
12
This review examined the potential of red blood cells (RBCs) as biomarkers of aging. Researchers found that age-related increases in red cell distribution width (RDW) reflect underlying shifts in erythropoiesis and cellular turnover. Despite promising indicators, challenges remain in establishing RBC parameters as definitive biomarkers of aging.
View on PubMed
#10

Prognostic value of red cell distribution width in patients undergoing percutaneous coronary intervention: a meta-analysis.

Meta-AnalysisInfluence1.0
10
This meta-analysis evaluated the prognostic value of baseline red cell distribution width (RDW) in patients undergoing percutaneous coronary intervention (PCI). Researchers found that higher RDW was associated with increased risks of all-cause mortality and major adverse cardiac events. The predictive effect was notably stronger in patients without anemia.
View on PubMed

Clinical Trials (3)

3

Total Trials

240

Total Enrolled

Red Cell Distribution Width as a Predictor for Post Operative Atrial Fibrillation After Open Heart Surgries

Sponsor

Ain Shams University

Enrollment

80

Started

2024

Primary outcome

Red cell distribution width as a predictor for Post-operative Atrial fibrillation after Open Heart Surgeries

Atrial FibrillationInflammatory MarkerHeart; Surgery, Heart, Functional Disturbance as Result

Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients

NCT06847451COMPLETED
Sponsor

Ain Shams University

Enrollment

60

Started

2024

Primary outcome

Assessment of prognostic value of Red Cell Distribution Width in septic Intensive care units patients for 28 days mortality.

Sepsis

The Effect of Biomarkers of Inflammation on Graft Function in Kidney Transplantation

Sponsor

Ankara City Hospital Bilkent

Enrollment

100

Started

2023

Primary outcome

RDW

Renal Transplant Failure and RejectionInflammation

Publication Trend

Research publications about RDW over time

9total
2
'13
1
'19
1
'20
2
'22
2
'24
1
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer